SCHEMBL20779641

SCHEMBL20779641

CCn1cnc(-c2cc(SNC)ccc2C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 3/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2E1 P05181 1/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ CYP2B6 P20813 1/20 0.40
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ CYP1A2 P05177 2/20 0.31
▸ CYP2D6 P10635 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ KAT6A Q92794 1/20 0.31
▸ IRAK4 Q9NWZ3 1/20 0.30
▸ METTL3 Q86U44 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20779720 0.81 LRRK2 (0.39) CYP2C19CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL20779628 0.76 KAT6A (0.34) CYP2C19CYP3A4CYP2C9CYP2E1CYP2A6
SCHEMBL20779671 0.75 TEAD1 (0.50) CYP2C19CYP3A4CYP2C9CYP2E1CYP2A6
SCHEMBL11962891 0.70 CYP3A4 (0.46) CYP2C19CYP3A4CYP2C9CYP2E1CYP2A6
SCHEMBL11951599 0.66 CYP3A4 (0.42) CYP2C19CYP3A4CYP2C9CYP2E1CYP2A6
SCHEMBL20779813 0.66 LRRK2 (0.41) CYP2C19CYP2C9CYP2E1CYP2A6CYP2B6
SCHEMBL2910946 0.63 CYP2E1 (0.67) CYP2C19CYP3A4CYP2C9CYP2E1CYP2A6
SCHEMBL8036070 0.61 CYP3A4 (0.43) CYP3A4ALDH1A1GAAALOX15RAB9A
SCHEMBL18663454 0.61 TSHR (0.43) CYP2C19CYP3A4CYP2C9CYP1A2CYP2D6
SCHEMBL10994298 0.61 CYP3A4 (0.54) CYP2C19CYP3A4CYP2C9CYP2E1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019040380-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2019-02-28 — — WO disclosed
Send feedback